Company: NCEL
Filing Date: 2025-07-18
Form Type: F-4/A
Source: 0001213900-25-065783
Chunk: 763

Company: NewcelX Ltd.
Filing Date: 2025-07-18
Form: F-4/A
Chunk 763
---
   |         — |     |            |  2,076,180 |   |     |              | (2,076,180  | ) |     |               |        — |   |     |       |           — |   |
| Net loss                                                      |     |                — |        |     |   |        — |        |     |             — |     |   |         — |     |            |          — |   |     |              | (1,980,810  | ) |     |               |        — |   |     |       |  (1,980,810 | ) |
| BALANCE, DECEMBER 31, 2024                                    |     |          206,452 |        |     | $ |  166,353 |        |     |     3,159,535 |     | $ | 2,740,958 |     | $          | 72,820,671 |   |     | $            | (74,430,474 | ) |     | $             |  108,853 |   |     | $     |   1,406,361 |   |

Adjusted for the effect of a 1 -to-40reverse share split that was effective September 27, 2024 (See note 2). The accompanying notes are an integral part of these consolidated financial statements.

Annex F-6

NLS PHARMACEUTICS LTD. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF CASH FLOWS

| Cash Flows From Operating Activities:                                                   |     | For the Years Ended December 31, 
 2024                             |            |   |     | 2023 |             |   |     | 2022 |             |   |
|:----------------------------------------------------------------------------------------|:----|:---------------------------------|-----------:|:--|:----|:-----|------------:|:--|:----|:-----|------------:|:--|
| Net loss                                                                                |     | $                                | (1,980,810 | ) |     | $    | (12,172,029 | ) |     | $    | (16,495,680 | ) |
| Adjustments to reconcile net loss to net cash used in operating activities:             |     |                                  |            |   |     |      |             |   |     |      |             |   |
| Periodic pension costs                                                                  |     |                                  |